Showing 12 authorised medicines
Medicine Active substance Licence holder Status
Lisdexamfetamine dimesylate Rowex 20 mg hard capsules PA0711/352/001
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 30 mg hard capsules PA0711/352/002
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 40 mg hard capsules PA0711/352/003
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 50 mg hard capsules PA0711/352/004
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 60 mg hard capsules PA0711/352/005
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Lisdexamfetamine dimesylate Rowex 70 mg hard capsules PA0711/352/006
Lisdexamfetamine dimesylate
Rowex Limited, Not marketed
Tyvense 20 mg capsules, hard PA23211/005/001
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Tyvense 30 mg capsules, hard PA23211/005/002
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Tyvense 40 mg capsules, hard PA23211/005/003
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Tyvense 50 mg capsules, hard PA23211/005/004
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Tyvense 60 mg capsules, hard PA23211/005/005
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Tyvense 70 mg capsules, hard PA23211/005/006
Lisdexamfetamine dimesylate
Takeda Pharmaceuticals International AG Ireland Branch Marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.